Alinco Incorporated (TYO:5933)
Japan · Delayed Price · Currency is JPY 1,057.00
+13.00 (1.25%)
Aug 1, 2025, 3:30 PM JST
Ligand Pharmaceuticals Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2017 - 2021 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 20, 2025 | Mar '25 Mar 20, 2025 | Mar '24 Mar 20, 2024 | Mar '23 Mar 20, 2023 | Mar '22 Mar 20, 2022 | Mar '21 Mar 20, 2021 | 2017 - 2021 |
Net Income | - | 3,002 | 3,022 | 3,302 | 1,363 | 2,923 | Upgrade |
Depreciation & Amortization | - | 2,520 | 3,558 | 3,308 | 3,312 | 3,532 | Upgrade |
Loss (Gain) From Sale of Assets | - | 18 | - | 14 | 6 | 71 | Upgrade |
Loss (Gain) From Sale of Investments | - | -64 | -142 | -30 | -67 | -120 | Upgrade |
Loss (Gain) on Equity Investments | - | - | - | 170 | 878 | 18 | Upgrade |
Other Operating Activities | - | -480 | -1,879 | -527 | -1,029 | -1,248 | Upgrade |
Change in Accounts Receivable | - | 58 | 603 | -330 | -277 | 841 | Upgrade |
Change in Inventory | - | 824 | -2,046 | -3,555 | -2,609 | -275 | Upgrade |
Change in Accounts Payable | - | -6 | -1,655 | 114 | 1,521 | -723 | Upgrade |
Change in Other Net Operating Assets | - | -448 | 224 | 222 | -387 | 274 | Upgrade |
Operating Cash Flow | - | 5,424 | 1,685 | 2,688 | 2,711 | 5,293 | Upgrade |
Operating Cash Flow Growth | - | 221.90% | -37.31% | -0.85% | -48.78% | 8.22% | Upgrade |
Capital Expenditures | - | -5,580 | -5,353 | -3,513 | -3,289 | -3,325 | Upgrade |
Sale of Property, Plant & Equipment | - | 12 | 15 | 1 | 5 | 1 | Upgrade |
Cash Acquisitions | - | -10 | - | -166 | -596 | -1,500 | Upgrade |
Sale (Purchase) of Intangibles | - | -51 | -44 | -51 | -66 | -82 | Upgrade |
Investment in Securities | - | 218 | 97 | 43 | 233 | 310 | Upgrade |
Other Investing Activities | - | -145 | -34 | -2 | 71 | 19 | Upgrade |
Investing Cash Flow | - | -5,560 | -5,332 | -3,723 | -3,664 | -4,681 | Upgrade |
Short-Term Debt Issued | - | 1,254 | - | - | 2,359 | - | Upgrade |
Long-Term Debt Issued | - | 8,180 | 13,635 | 10,400 | 4,820 | 7,236 | Upgrade |
Total Debt Issued | - | 9,434 | 13,635 | 10,400 | 7,179 | 7,236 | Upgrade |
Short-Term Debt Repaid | - | - | -777 | -648 | - | -705 | Upgrade |
Long-Term Debt Repaid | - | -8,786 | -8,487 | -6,525 | -5,882 | -5,441 | Upgrade |
Total Debt Repaid | - | -8,786 | -9,264 | -7,173 | -5,882 | -6,146 | Upgrade |
Net Debt Issued (Repaid) | - | 648 | 4,371 | 3,227 | 1,297 | 1,090 | Upgrade |
Issuance of Common Stock | - | 112 | 108 | 118 | 112 | - | Upgrade |
Repurchase of Common Stock | - | - | - | - | - | -472 | Upgrade |
Dividends Paid | - | -836 | -796 | -794 | -773 | -743 | Upgrade |
Other Financing Activities | - | -27 | -31 | -14 | -53 | -32 | Upgrade |
Financing Cash Flow | - | -103 | 3,652 | 2,537 | 583 | -157 | Upgrade |
Foreign Exchange Rate Adjustments | - | 401 | -10 | 45 | 37 | -92 | Upgrade |
Miscellaneous Cash Flow Adjustments | - | -1 | - | - | 1 | 58 | Upgrade |
Net Cash Flow | - | 161 | -5 | 1,547 | -332 | 421 | Upgrade |
Free Cash Flow | - | -156 | -3,668 | -825 | -578 | 1,968 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | 9.15% | Upgrade |
Free Cash Flow Margin | - | -0.25% | -6.34% | -1.36% | -1.05% | 3.69% | Upgrade |
Free Cash Flow Per Share | - | -7.87 | -186.41 | -42.24 | -29.82 | 100.86 | Upgrade |
Cash Interest Paid | - | 159 | 90 | 65 | 48 | 48 | Upgrade |
Cash Income Tax Paid | - | 625 | 1,885 | 531 | 1,206 | 1,249 | Upgrade |
Levered Free Cash Flow | - | -641.88 | -4,768 | -1,529 | -1,543 | 1,655 | Upgrade |
Unlevered Free Cash Flow | - | -542.5 | -4,708 | -1,487 | -1,512 | 1,685 | Upgrade |
Change in Net Working Capital | -725.97 | -1,196 | 3,983 | 2,744 | 2,168 | 36 | Upgrade |
Updated Feb 3, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.